Literature DB >> 8537400

Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody.

J van den Born1, K Gunnarsson, M A Bakker, L Kjellén, M Kusche-Gullberg, M Maccarana, J H Berden, U Lindahl.   

Abstract

Immunohistochemical application of antibodies against heparan sulfate proteoglycan core protein and heparitinase-digested heparan sulfate stubs showed the presence of heparan sulfate proteoglycan in all basement membranes of the rat kidney. However, a monoclonal antibody (JM-403) against native heparan sulfate (van den Born, J., van den Heuvel, L. P. W. J., Bakker, M. A. H., Veerkamp, J. H., Assmann, K. J. M., and Berden, J. H. M. (1992) Kidney Int. 41, 115-123) largely failed to stain tubular basement membranes, suggesting the presence of heparan sulfate chains lacking the specific JM-403 epitope. Heparan sulfate preparations from various sources differed markedly with regard to JM-403 binding, as demonstrated by liquid phase inhibition in enzyme-linked immunosorbent assay, the interaction decreasing with increasing sulfate contents of the polysaccharide. Mapping of the JM-403 epitope indicated that it was dominated by one or more N-unsubstituted glucosamine unit(s), since treatments that destroyed or altered the structure of such units in heparan sulfate preparations (cleavage at N-unsubstituted glucosamine units with HNO2 at pH 3.9 and N-acetylation with acetic anhydride, respectively), abolished antibody binding. Conversely, immunoreactivity could be induced in a (D-glucuronyl-1,4-N-acetyl-D-glucosaminyl-1,4) polysaccharide by the generation of N-unsubstituted glucosamine N-unsubstituted glucosamine in a JM-403-binding heparan sulfate (preparation HS-II from human aorta) was demonstrated by an approximately 3-fold reduction in molecular size following HNO2 (pH 3.9) treatment. Further characterization of the epitope recognized by JM-403, based on enzyme-linked immunosorbent assay inhibition tests with chemically/enzymatically modified polysaccharides, indicated that one or more N-sulfated glucosamine units are invariable present, whereas L-iduronic acid and O-sulfate residues appear to inhibit JM-403 reactivity. It is concluded that the epitope contains one or more N-unsubstituted glucosamine and D-glucuronic acid units and is located in a region of the heparan sulfate chain composed of mixed N-sulfated and N-acetylated disaccharide units.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537400     DOI: 10.1074/jbc.270.52.31303

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.

Authors:  S Tomatsu; M A Gutierrez; T Ishimaru; O M Peña; A M Montaño; H Maeda; S Velez-Castrillon; T Nishioka; A A Fachel; A Cooper; M Thornley; E Wraith; L A Barrera; L S Laybauer; R Giugliani; I V Schwartz; G Schulze Frenking; M Beck; S G Kircher; E Paschke; S Yamaguchi; K Ullrich; K Isogai; Y Suzuki; T Orii; A Noguchi
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Temporal and functional changes in glycosaminoglycan expression during osteogenesis.

Authors:  Victor Nurcombe; Fuqi Jack Goh; Larisa M Haupt; Sadasivam Murali; Simon M Cool
Journal:  J Mol Histol       Date:  2007-08-03       Impact factor: 2.611

5.  Cytoplasmic expression of the JM403 antigen GlcA-GlcNH3+ on heparan sulfate glycosaminoglycan in mammary carcinomas--a novel proliferative biomarker for breast cancers with high malignancy.

Authors:  Masahiro Fujii; Akiko Yusa; Yukihiro Yokoyama; Toshio Kokuryo; Nobuyuki Tsunoda; Koji Oda; Masato Nagino; Tsuyoshi Ishimaru; Yoshie Shimoyama; Hirotoshi Utsunomiya; Hiroji Iwata; Yoshiko Itoh; Johbu Itoh; Reiji Kannagi; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2010-11-03       Impact factor: 2.916

6.  Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.

Authors:  Satomi Nadanaka; Eko Purunomo; Naoko Takeda; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

7.  Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies.

Authors:  Zheng Wei; Jon Andrew Deakin; Bärbel Sabine Blaum; Dušan Uhrín; John Thomas Gallagher; Malcolm Lyon
Journal:  Glycoconj J       Date:  2011-09-21       Impact factor: 2.916

8.  Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.

Authors:  Azadeh Zaferani; Romain R Vivès; Pieter van der Pol; Gerjan J Navis; Mohamed R Daha; Cees van Kooten; Hugues Lortat-Jacob; Marc A Seelen; Jacob van den Born
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

9.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

10.  Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.

Authors:  Heleen Rienstra; Kirankumar Katta; Johanna W A M Celie; Harry van Goor; Gerjan Navis; Jacob van den Born; Jan-Luuk Hillebrands
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.